The use of allograft skin in burn care
Abstract
The article reviews the current methods and indications for the use of allograft skin in the management of burns, as well as the prospects for application of the allografts in tissue engineering.
About the Author
A. S. PleshkovRussian Federation
References
1.
2. Peck M., Pressman M.A. The correla- tion between burn mortality rates from fire and flame and economic status of countries. Burns. 2013; 39 (6): 1054–1059.
3. Paramonov B.A., Porembskiy Ya.O., Yablonskiy V.G. Ozhogi: rukovodstvo dlya vrachey [Burns: A Guide for Phy- sicians]. Saint Petersburg: SpetsLit Publ., 2000. 488 p. (In Russian).
4. Lumenta D.B., Kamolz L.P., Frey M. Adult burn patients with more than 60% TBSA involved – Meek and other tech- niques to overcome restricted skin har- vest availability – the Viennese concept. J Burn Care Res. 2009; 30 (2): 231–242.
5. Böttcher-Haberzeth S., Biedermann T., Reichmann E. Tissue engineering of skin. Burns. 2010; 36 (4): 450–460.
6. Kamolz L.P., Lumenta D.B., Kitz- inger H.B., Frey M. Tissue engineering for cutaneous wounds: an overview of current standards and possibilities. Eur Surg. 2008; 40: 19–26.
7. Herndon D.N., ed. Total Burn Care. 4th ed. Elsevier, 2012. 808 p.
8. Herndon D.N. Perspectives in the use of allograft. J Burn Care Rehabil. 1997; 18(1)Pt2:6.
9. Kagan R.J., Robb E.C., Plessinger R.T. Human Skin Banking. Clin Lab Med. 2005; 25: 587–605.
10. Klasen H.J. History of Burns. Rotter- dam: Erasmus Publishing, 2004. 632 p.
11. Medawar P.B. Immunity to homol- ogous grafted skin: the relationship between the antigens of blood and skin. Br J Exp Pathol. 1946; 27: 15–24.
12. Mirskiy M.B. Istoriya otechestvennoy transplantologii [The history of nation- al transplantation]. Moscow: Meditsina Publ., 1985. 240 p. (In Russian).
13. Smirnov S.V., Loginov L.P., Borisov V.S., Rodchenkova E.M. Khirurgicheskoe lechenie tyazhelykh ozhogov na sovre- mennom etape [Surgical treatment of severe burns at the present stage]. In: Khirurgicheskoe lechenie ozhogov i ikh posledstviy: tez. dokl. mezhregion. nauch.-prakt. konf., g. N. Novgorod, 6-8 iyunya 2012 g. [Surgical treatment of burns and their consequences: abstracts interregional scientific-practical confer- ence, Nizhny Novgorod, 6-8 June 2012]. Voprosy travmatologii i ortopedii: elek- tronnyy zhurnal. 2012; 2 (3): 87. Available at: www.vto-journal.ru (In Russian).
14. Chmyrev I.V. Nekrektomiya u obozhzhennykh: Innovatsionnye pod- khody pri okazanii spetsializirovannoy meditsinskoy pomoshchi: dis. ... d-ra med. nauk [Necrosectomy have baked: Innovative approaches in the provision of specialized medical care. Dr. med. sci. diss.]. Saint Petersburg, 2014. 301 p. (In Russian).
15. Bravo D., Rigley T.H., Gibran N., et al. Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns. 2000; 26 (6): 367–378.
16. Vloemans A., Middelkoop E., Kreis R. A historical appraisal of the use of cryopreserved and glycerol-preserved allograft skin in the treatment of partial thickness burns. Burns. 2002; 28: 16–20.
17. Savel'ev V.I., Kornilov N.V., Kalinin A.V. Aktual'nye problemy transplantatsii tkaney [Actual problems of tissue trans- plantation]. Saint Petersburg: MorsarAV Publ., 2001. 157 p. (In Russian).
18. Pruitt B.A., Levine N.S. Character- istics and uses of biologic dressings and skin substitutes. Arch Surg. 1984; 119 (3): 312–322.
19. Ben-Bassat H., Chaouat M., Segal N., et al. How long can cryopreserved skin be stored to maintain adequate graft per- formance? Burns. 2001; 27 (5): 425–431.
20. Hermans M. Preservation methods of allografts and their influence on clinical results in partial thickness burns. Burns. 2011; 37 (5): 873–881.
21. Fahmy F.S., Navsaria H.A., Frame J.D., et al. Skin graft storage and kera- tinocyte viability. Br J Plast Surg. 1993; 46 (4): 292–295.
22. Mackie D. The Euro skin bank: devel- opment and application of glycerol-pre- served allografts. J Burn Care Rehabil. 1997; 18 (1): Pt. 2. 7–9.
23. Saegeman V., Ectors N., Lismont D., et al. Short- and long-term bacterial inhib- iting effect of high concentrations of glycerol used in the preservation of skin allografts. Burns. 2008; 34 (2): 205–211.
24. Richters C.D., Hoekstra M.J., van Baare J., et al. Immunogenicity of glyc- erol-preserved human cadaver skin in vitro. J Burn Care Rehabil. 1997; 18 (3): 228–233.
25. Atiyeh B., Hayek S., Gunn S. New technologies for burn wound closure and healing – Review of the literature. Burns. 2005; 31 (8): 944–956.
26. Garfein E.S., Orgill D.P., Pribaz J.J. Clinical applications of tissue engineered constructs. Clin Plast Surg. 2003; 30 (4): 485–498.
27. Greaves N., Lgbal S., Morris J., et al. Acute cutaneous wounds treated with human decellularised dermis show enhanced angiogenesis during healing. PLoS One. 2015; 10 (1): e0113209.
28. Shevchenko R.V., James S., James E. A review of tissue-engineered skin bioconstructs available for skin recon- struction. J R Soc Interface. 2010; 7 (43): 229–258.
29. Rose J.K., Desai M.H., Mlakar J.M., et al. Allograft is superior to topical antimi- crobial therapy in the treatment of par- tial-thickness scald burns in children. J Burn Care Rehabil. 1997; 18 (4): 338–341.
30. Naoum J.J., Roehl K.R., Wolf S.E., et al. The use of homograft compared to topical antimicrobial therapy in the treatment of second-degree burns of more than 40% total body surface area. Burns. 2004; 30 (6): 548–551.
31. Alexander J.W., MacMillan B.G., Law E., Kittur D.S. Treatment of severe burns with widely meshed skin autograft and widely meshed skin allograft overlay. J Trauma. 1981; 21 (6): 433–438.
32. Zhang M.L., Chang Z.D., Wang C.Y., et al. Microskin grafting in the treatment of extensive burns: a preliminary report. J Trauma. 1988; 28 (6): 804–807.
33. Cuono C., Langdon R., McGuire J. Use of cultured autografts and dermal allografts as skin replacement after burn injury. Lancet. 1986; 1: 1123–1124.
34. Grafting of burns with cultured epi- thelium prepared from autologous epi- dermal cells. Lancet. 1981; 1: 75–78.
35. Hickerson W.L., Compton C., Fletchall S., Smith L.R. Cultured epidermal auto- grafts and allodermis combination for permanent burn wound coverage. Burns. 1994; 20 Suppl 1: 52–56.
36. Livesey S.A., Herndon D.N., Hol- lyoak M.A., et al. Transplanted acellular allograft dermal matrix. Transplantation. 1995; 60 (1): 1–9.
37. Wainwright D.J., Bury S.B. Acellu- lar dermal matrix in the management of the burn patient. Aesthet Surg J. 2011; 31 (Suppl. 7): 13–23.
38. Pirayesh A., Hoeksema H., Rich- ters C., et al. Glyaderm dermal substi- tute: clinical application and long-term results in 55 patients. Burns. 2015; 41 (1): 132–144.
39. Bloemen M., van der Wal M., Ver- haegen P., et al. Clinical effectiveness of dermal substitution in burns by topical negative pressure: a multicenter ran- domized controlled trial. Wound Repair Regen. 2012; 20 (6): 797–805.
40. Deshpande P., Ralston D.R., MacNeil S. The use of allodermis prepared from Euro skin bank to prepare autologous tissue engineered skin for clinical use. Burns. 2013; 39 (6): 1170–1177.
41. Schiestl C., Biedermann T., Braziulis E., et al. Skingineering II: transplanta- tion of large-scale laboratory-grown skin analogues in a new pig model. Pediatr Surg Int. 2011; 27 (3): 249–254.
42. Biedermann T., Böttcher-Haber- zeth S., Klar A.S., et al. The influence of stromal cells on the pigmentation of tissue-engineered dermo-epidermal skin grafts. Tissue Eng Part A. 2015; 21 (5-6): 960–969.
43. Monafo W.W., Tandon S.N., Bradley R.E., et al. Bacterial contamination of skin used as a biologic dressing: a potential hazard. JAMA. 1976; 235 (12): 1248–1249.
44. White M.J., Whalen J.D., Gould J.A., et al. Procurement and transplantation of colonized cadaver skin. Am Surg. 1991; 57 (6): 402–407.
45. Hornicek F.J., Woll J., Kasprisin D. Standardes for Tissue Banking. 10th ed. AATB, McLean, VA, 2002. 112 p.
46. Rooney P., Eagle M., Hogg P., et al. Sterilisation of skin allograft with gamma irradiation. Burns. 2008; 34 (5): 664–673.
47. Clarke J.A. HIV transmission and skin grafts. Lancet. 1987; 1: 983.
48. Kealey G.P., Aguiar J., Lewis R.W., et al. Cadaver skin allografts and transmis- sion of human cytomegalovirus to burn patients. J Am Coll Surg. 1996; 182 (3): 201–205.
49. Herndon D.N., Rose J.K. Cadaver skin allograft and the transmission of human cytomegalovirus in burn patients: ben- efits clearly outweigh. J Am Coll Surg. 1996; 182 (3): 263–264.
50. Plessinger R.T., Robb E.C., Kagan R.J. Cytomegalovirus in skin donors. Proc. AATB. 1996; 20: 56 p.
51. Ninnemann J.L., Fisher J.C., Frank H.A. Prolonged survival of human skin allografts following thermal injury. Transplantation. 1978; 25 (2): 69–72.
52. Burke J.F., May J.B., Albright N., et al. Temporary skin transplantation and immunosuppression for extensive burns. N Engl J Med. 1974; 290 (5): 269–271.
53. Achauer B.M., Hewitt C.W., Black K.S., et al. Long-term allograft survival after short-term cyclosporin treatment in a patient with massive burns. Lancet. 1986; 1: 14–15.
Review
For citations:
Pleshkov A.S. The use of allograft skin in burn care. Transplantologiya. The Russian Journal of Transplantation. 2016;(1):36-46.